X

The Health Sciences Blog covers the latest trends and advances in life sciences and healthcare.

Leadership Position in Life Sciences Clinical Trials Products Recognized by The Everest Group

The Everest Group recently recognized Oracle Health Sciences as maintaining a strong leadership position in the marketplace for Life Sciences Clinical Trials Products. In their PEAK Matrix Assessment™ 2019 Assessment of Life Sciences Clinical Trials Products, Everest Group recognized Oracle as having the strongest eClinical capabilities and vision among all 16 vendors evaluated.

Everest Group called Oracle Health Sciences a front runner in supporting life sciences organizations looking to achieve digital transformation within clinical trials. They specifically noted both our work to “build a holistic set of offerings,” as well as our “integrated end-to-end vision.”

 

 

Jim Streeter,
Global Vice President,
Life Sciences Product Strategy,
Oracle Health Sciences

"We’re grateful for this recognition of our efforts to integrate all aspects of our clinical trial offerings in ways that streamline every part of the clinical trial process. Our goal has been to enable companies to simplify, accelerate, and unify their clinical trials, by streamlining and automating processes, while eliminating manual and redundant data entry and activities. This is our promise and what we deliver with Clinical One, which helps our customers compete in a marketplace where both time-to-market and study efficiency are critical to success."

 

The application of digital technology across trials is becoming more common every day, and Oracle Health Sciences is providing the tools our customers need to address that change, too. Whether it’s real-time data from patient sensors or external environmental data, we want to ensure our customers can analyze the complete spectrum of relevant clinical information and gain new insights.

Oracle Health Sciences appreciates this recognition of our efforts to support the vital work of the Life Sciences industry to develop novel and advanced treatments for serious, life-threatening conditions that are affecting people all over the world. We’ll continue to devote ourselves to responding to the market to make sure we are always delivering innovation to improve the safety and efficiency of clinical research.

You can download the full Everest PEAK Matrix Assessment 2019 report here.

Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.